Kern Pharma, a leader producer of generic medicines belonging to Grupo Indukern, completes the acquisition of 100% of the pharmaceutical company Gynea Laboratorios, specialised in women’s health care

Founded in 1999, Gynea Laboratorios is based in Barcelona and has a subsidiary in Chile. The company employs 78 people and focuses on the development and commercialisation of food supplements, dermocosmetics and medicines, especially for women’s health care.

Kern Pharma, also founded in 1999, has a workforce of more than 600 professionals and produces more than 100 million generic medicines per year. The company belongs to Grupo Indukern, a Spanish multinational with subsidiaries in 19 countries, a commercial presence in more than 70 and consolidated sales of € 676 million (2012).

With this acquisition, Kern Pharma expands its offer in the gynaecology area, with products focusing on maternity and protection.

SOCIOS FINANCIEROS acts as advisor to Gynea Laboratorios shareholders in the design, negotiation and execution of the transaction.